Business Context and Reporting Period
This Form 8-K, dated June 29, 2015, reports that Willis Group Holdings plc ("Willis") entered into a definitive Merger Agreement with Towers Watson & Co. ("Towers Watson"). The transaction involves a stock-for-stock merger where Willis will acquire Towers Watson, creating a combined entity to be named Willis Towers Watson plc. The filing also details concurrent executive leadership changes and employment agreement amendments conditioned on the merger's closing.
Key Financial Metrics and Transaction Terms
The filing outlines the specific financial consideration for the merger rather than historical operating metrics:
- Exchange Ratio: Each share of Towers Watson Class A common stock will be converted into 2.6490 ordinary shares of Willis.
- Special Dividend: Towers Watson intends to declare a pre-merger special cash dividend of $4.87 per share.
- Termination Fees: Both parties are subject to a termination fee of $255 million under specific conditions (e.g., change of recommendation, failure to close by the outside date, or acceptance of a superior proposal). Additionally, there is a provision for reimbursement of out-of-pocket fees and expenses up to $45 million.
- Executive Compensation: Dominic Casserley's amended agreement provides a $1 million annual base salary, a target bonus of 225% of base, and an equity award valued at 525% of base for fiscal 2016. Severance benefits include two times base salary and two times target bonus upon qualifying termination.
Note: This filing does not provide historical revenue, profit, cash flow, or debt figures for either company.
Material Changes and Leadership Restructuring
Upon closing, the following material changes to corporate structure and leadership are planned:
- Corporate Name: Willis Group Holdings plc will change its name to Willis Towers Watson plc.
- Stock Consolidation: Willis will effect a reverse stock split (consolidation) where every 2.6490 ordinary shares will be consolidated into one ordinary share.
- Board Composition: The combined board will consist of 12 directors, with six designated by Willis and six by Towers Watson.
- Executive Roles:
- John J. Haley (Towers Watson) will be appointed Chief Executive Officer and Chairman.
- Dominic Casserley (Willis) will resign as CEO and be appointed President and Deputy Chief Executive Officer until December 31, 2016.
Guidance, Risks, and Conditions
The transaction is subject to numerous conditions, including shareholder approval from both companies, regulatory approvals (including the Hart-Scott-Rodino Act), and the absence of material adverse effects. The "Outside Date" for closing is March 31, 2016.
Key Risks and Contingencies:
- Regulatory and Shareholder Approval: Failure to obtain necessary approvals could result in termination and payment of termination fees.
- Integration Risks: The filing highlights risks regarding the ability to successfully integrate operations, realize synergies, and manage the combined workforce.
- Market Conditions: General economic, business, and political conditions could impact the transaction.
- Forward-Looking Statements: Actual results may differ materially from projections due to uncertainties in the merger process.
Investor Verification Checklist
- Verify the final approval status of the merger by both Willis and Towers Watson shareholders.
- Confirm the receipt of all necessary regulatory and antitrust clearances.
- Review the upcoming Joint Proxy Statement/Prospectus (Form S-4) for detailed financial data and risk factors not included in this 8-K.
- Monitor the status of the special $4.87 per share dividend declaration by Towers Watson.
- Assess the potential impact of the $255 million termination fee provisions on both companies' balance sheets if the deal fails.